Nickel Compounds Act through Phosphatidylinositol-3-kinase/Akt-Dependent, p70S6k-Independent Pathway to Induce Hypoxia Inducible Factor Transactivation and Cap43 Expression in Mouse Epidermal C141 Cells

Cancer Research

Volumn 64, Issue 1, 2004, Pages 94-101

  Li, Jingxia ^a   Davidson, Gerard ^a   Huang, Yi ^a   Jiang, Bing Hua ^b   Shi, Xianglin ^c   Costa, Max ^a   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; NICKEL; NICKEL CHLORIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN P70; RAPAMYCIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIDERMIS CELL; GENE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ANIMALS; CARCINOGENS; CELL CYCLE PROTEINS; CELL LINE; ENZYME ACTIVATION; EPIDERMIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; NICKEL; PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 1642494851     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-0737     Document Type: Article

References (54)

1. Costa, M. Molecular mechanisms of nickel carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 31: 321-337, 1991.
2. Biedermann, K. A., and Landolph, J. R. Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res., 47: 3815-3823, 1987.
3. Oller, A. R., Costa, M., and Oberdorster, G. Carcinogenicity assessment of selected nickel compounds. Toxicol. Appl. Pharmacol., 143: 152-166, 1997.
4. Knight, J. A., Plowman, M. R., Hopfer, S. M., and Sunderman, F. W. Pathological reactions in lung, liver, thymus, and spleen of rats after subacute parenteral administration of nickel sulfate. Ann. Clin. Lab. Sci., 21: 275-283, 1991.
5. Tveito, G., Hansteen, I. L., Dalen, H., and Haugen, A. Immortalization of normal human-kidney epithelial-cells by nickel(II). Cancer Res., 49: 1829-1835, 1989.
6. Miura, T., Patierno, S. R., Sakuramoto, T., and Landolph, J. R. Morphological and neoplastic transformation of C3H/10T1/2 Cl 8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ. Mol. Mutagen., 14: 65-78, 1989.
7. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans-Chromium, Nickel, and Welding, Vol. 49, pp. 677. Lyon, France: IARC, 1990.
8. Semenza, G. L. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol., 13: 167-171, 2001.
9. Aebersold, D. M., Burri, P., Beer, K. T., Laissue, J., Djonov, V., Greiner, R. H., and Semenza, G. L. Expression of hypoxia-inducible factor-1 α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res., 61: 2911-2916, 2001.
10. Birner, P., Schindl, M., Obermair, A., Plank, C., Breitenecker, G., and Oberhuber, G. Overexpression of hypoxia-inducible factor 1 α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res., 60: 4693-4696, 2000.
11. Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C. M., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J., and van der Wall, E. Levels of hypoxia-inducible factor-1 α during breast carcinogenesis. J. Natl. Cancer Inst. (Bethesda), 93: 309-314, 2001.
12. Talks, K. L., Turley, H., Gatter, K. C., Maxwell, P. H., Pugh, C. W., Ratcliffe, P. J., and Harris, A. L. The expression and distribution of the hypoxia-inducible factors HIF-1 α and HIF-2 α in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol., 157: 411-421, 2000.
13. Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., and Semenza, G. L. Expression of hypoxia-inducible factor 1 α in brain tumors: association with angiogenesis, invasion, and progression. Cancer (Phila.), 88: 2606-2618, 2000.
14. Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., Buechler, P., Isaacs, W. B., Semenza, G. L., and Simons, J. W. Overexpression of hypoxia-inducible factor 1 α in common human cancers and their metastases. Cancer Res., 59: 5830-5835, 1999.
15. Maxwell, P. H., Wiesener, M. S., Chang, G. W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe, P. J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (Lond.), 399: 271-275, 1999.
16. Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q. W., Dillehay, L. E., Madan, A., Semenza, G. L., and Bedi, A. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1 α. Genes Dev., 14: 34-44, 2000.
17. Salnikow, K., An, W. G., Melillo, G., Blagosklonny, M. V., and Costa, M. Nickel-induced transformation shifts the balance between HIF-1 and p53 transcription factors. Carcinogenesis (Lond.), 20: 1819-1823, 1999.
18. Jiang, B. H., Agani, F., Passaniti, A., and Semenza, G. L. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: Involvement of HIF-1 in tumor progression. Cancer Res., 57: 5328-5335, 1997.
19. Richard, D. E., Berra, E., Gothie, E., Roux, D., and Pouyssegur, J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1 α (HIF-1 α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem., 274: 32631-32637, 1999.
20. Zhong, H., Chiles, K., Feldser, D., Laughner, E., Hanrahan, C., Georgescu, M. M., Simons, J. W., and Semenza, G. L. Modulation of hypoxia-inducible factor 1 α expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT1 FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res., 60: 1541-1545, 2000.
21. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., Stokoe, D., and Giaccia, A. J. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev., 14: 391-396, 2000.
22. 2 sensing. Science (Wash. DC), 292: 464-468, 2001.
23. 2-regulated prolyl hydroxylation. Science (Wash. DC), 292: 468-472, 2001.
24. Sutter, C. H., Laughner, E., and Semenza, G. L. Hypoxia-inducible factor 1 α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. USA, 97: 4748-4753, 2000.
25. Andrew, A. S., Klei, L. R., and Barchowsky, A. Nickel requires hypoxia-inducible factor-1 α, not redox signaling, to induce plasminogen activator inhibitor-1. Am. J. Physiol. Lung Cell. Mol. Physiol., 281: L607-L615, 2001.
26. Barchowsky, A., Soucy, N. V., O'Hara, K. A., Hwa, J., Noreault, T. L., and Andrew, A. S. Novel pathway for nickel-induced interleukin-8 expression. J. Biol. Chem., 277: 24225-24231, 2002.
27. Salnikow, K., Costa, M., Figg, W. D., and Blagosklonny, M. V. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res., 60: 5630-5634, 2000.
28. + cells. Mol. Cell. Biol., 16: 6427-6435, 1996.
29. Huang, C., Schmid, P. C., Ma, W. Y., Schmid, H. H., and Dong, Z. Phosphatidylinositol-3 kinase is necessary for 12-O-tetradecanoylphorbol-13-acetate-induced cell transformation and activated protein 1 activation. J. Biol. Chem., 272: 4187-4194, 1997.
30. Huang, C., Li, J., Ding, M., Leonard, S. S., Wang, L., Castranova, V., Vallyathan, V., and Shi, X. UV induces phosphorylation of protein kinase B (Akt) at Ser-473 and Thr-308 in mouse epidermal Cl41 cells through hydrogen peroxide. J. Biol. Chem., 276: 40234-40240. 2001.
31. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
32. Jiang, B. H., Jiang, G. Q., Zheng, J. Z., Lu, Z. M., Hunter, T., and Vogt, P. K. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor. Cell Growth Different., 12: 363-369, 2001.
33. Colburn, N. H., Former, B. F., Nelson, K. A., and Yuspa, S. H. Tumour promoter induces anchorage independence irreversibly. Nature (Lond.), 281: 589-591, 1979.
34. Huang, C., Mattjus, P., Ma, W. Y., Rincon, M., Chen, N. Y., Brown, R. E., and Dong, Z. Involvement of nuclear factor of activated T cells activation in UV response. Evidence from cell culture and transgenic mice. J. Biol. Chem., 275: 9143-9149, 2000.
35. Huang, C., Ma, W., Ding, M., Bowden, G. T., and Dong, Z. Direct evidence for an important role of sphingomyelinase in ultraviolet-induced activation of c-Jun N-terminal kinase. J. Biol. Chem., 272: 27753-27757, 1997.
36. Aoki, M., Schetter, C., Himly, M., Batista, O., Chang, H. W., and Vogt, P. K. The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity. J. Biol. Chem., 275: 6267-6275, 2000.
37. Cantley, L. C., and Neel, B. G. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphonositide 3-kinase AKT pathway. Proc. Natl. Acad. Sci. USA, 96: 4240-4245, 1999.
38. Chang, H. W., Aoki, M., Fruman, D., Auger, K. R., Bellacosa, A., Tsichlis, P. N., Cantley, L. C., Roberts, T. M., and Vogt, P. K. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (Wash. DC), 276: 1848-1850, 1997.
39. Wymann, M. P., Bulgarelli-Leva, G., Zvelebil, M. J., Pirola, L., Vanhaesebroeck, B., Waterfield, M. D., and Panayotou, G. Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys802, a residue involved in the phosphate transfer reaction. Mol. Cell. Biol., 16: 1722-1733, 1996.
40. 2+ compounds. Cancer Res., 58: 2182-2189, 1998.
41. Cangul, H., Salnikow, K., Yee, H., Zagzag, D., Commes, T., and Costa, M. Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol. Toxicol., 18: 87-96, 2002.
42. Semenza, G. L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med., 8: S62-S67, 2002.
43. Jones, A., Fujiyama, C., Blanche, C., Moore, J. W., Fuggle, S., Cranston, D., Bicknell, R., and Harris, A. L. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 α and hypoxia-inducible factor-2 α in human bladder tumors and cell lines. Clin. Cancer Res., 7: 1263-1272, 2001.
44. Arsham, A. M., Plas, D. R., Thompson, C. B., and Simon, M. C. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 α nor sufficient for HIF-1-dependent target gene transcription. J. Biol. Chem., 277: 15162-15170, 2002.
45. Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., and Semenza, G. L. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 α (HIF-1 α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol., 21: 3995-4004, 2001.
46. Bernstein, L. R., and Colburn, N. H. APL/JUN function is differentially induced in promotion-sensitive and resistant JB6 cells. Science (Wash. DC), 244: 566-569, 1989.
47. Huang, C., Ma, W. Y., Young, M. R., Colburn, N., and Dong, Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl. Acad. Sci. USA, 95: 156-161, 1998.
48. Watts, R. G., Huang, C., Young, M. R., Li, J. J., Dong, Z., Pennie, W. D., and Colburn, N. H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene, 17: 3493-3498, 1998.
49. Karin, M., Liu, Z. G., and Zandi, E. AP-1 function and regulation. Curr. Opin. Biol., 9: 240-246, 1997.
50. Kokame, K., Kato, H., and Miyata, T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J. Biol. Chem., 271: 29659-29665, 1996.
51. van Belzen, N., Dinjens, W. N. M., Eussen, B. H. J., and Bosman, F. T. Expression of differentiation-related genes in colorectal cancer: possible implications for prognosis. Histol. Histopathol., 13: 1233-1242, 1998.
52. Guan, R. J., Ford, H. L., Fu, Y., Li, Y., Shaw, L. M., and Pardee, A. B. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res., 60: 749-755, 2000.
53. Kalaydjieva, L., Gresham, D., Gooding, R., Heather, L., Baas, F., de Jonge, R., Blechschmidt, K., Angelicheva, D., Chandler, D., Worsley, P., Rosenthal, A., King, R. H. M., and Thomas, P. K. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am. J. Human Genet., 67: 47-58, 2000.
54. Salnikow, K., Kluz, T., Costa, M., Piquemal, D., Demidenko, Z. N., Xie, K. P., and Blagosklonny, M. V. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol. Cell. Biol., 22: 1734-1741, 2002.